In 2023, Germany dominated the European sold production market of diagnostic reagents and pharmaceutical preparations with a significant share, followed by France and Italy. Germany's market share slightly increased, showcasing positive growth along with Italy and Denmark. Spain and Hungary experienced notable growth, whereas the Netherlands and Croatia faced declines in their market positions.
Future trends suggest continued dominance by Germany. However, emerging countries like Spain and Denmark may see substantial market share increases if current growth rates persist. Monitoring technological advancements and regulatory changes within these regions will be crucial for forecasting further market shifts.
Top countries in Sold Production of Diagnostic Reagents and Other Pharmaceutical Preparations Share by Country (Euros)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 57.85 | 2023 | +2.19% | +2.67% | View data |
| 2 | 2 France | 23.94 | 2023 | -1.63% | +0.66% | View data |
| 3 | 3 Italy | 13.63 | 2023 | +1.1% | +2.62% | View data |
| 4 | 4 Spain | 3.89 | 2023 | +7.86% | +5.37% | View data |
| 5 | 5 Denmark | 0.84 | 2023 | +0.91% | +8.29% | View data |
| 6 | 6 Hungary | 0.22 | 2023 | -1.05% | +6.02% | View data |
| 7 | 7 Poland | 0.16 | 2023 | +0.068% | View data | |
| 8 | 8 Czechia | 0.15 | 2023 | |||
| 9 | 9 Netherlands | 0.043 | 2023 | -0.079% | -64.48% | View data |
| 10 | 10 Sweden | 0.028 | 2023 | +7.67% | View data |
